Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir H Patel

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Advances in Radiation Oncology|July 11, 2022
The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal CancerRoman O Kowalchuk, Kathryn M Van Abel, Adam B Sauer, et al.
Advances in Radiation Oncology|May 8, 2023
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter ExperienceBrady S Laughlin, Sasha Ebrahimi, Molly M Voss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxMark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2019
Reply to A.S. GardenDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer PatientsJustin D Anderson, Todd A DeWees, Daniel J Ma, et al.
International Journal of Particle Therapy|October 23, 2020
The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck CancersJaden D Evans, Riley H Harper, Molly Petersen, et al.
Frontiers in Oncology|April 24, 2023
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planningJ John Lucido, Todd A DeWees, Todd R Leavitt, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Advances in Radiation Oncology|July 11, 2022
The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal CancerRoman O Kowalchuk, Kathryn M Van Abel, Adam B Sauer, et al.
Advances in Radiation Oncology|May 8, 2023
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter ExperienceBrady S Laughlin, Sasha Ebrahimi, Molly M Voss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxMark R Waddle, Daniel J Ma, Sue L Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2019
Reply to A.S. GardenDaniel J Ma, Katharine A Price, Eric J Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer PatientsJustin D Anderson, Todd A DeWees, Daniel J Ma, et al.
International Journal of Particle Therapy|October 23, 2020
The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck CancersJaden D Evans, Riley H Harper, Molly Petersen, et al.
Frontiers in Oncology|April 24, 2023
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planningJ John Lucido, Todd A DeWees, Todd R Leavitt, et al.
Pageof 11